Helen Susan Kim

AKTS

Helen Susan Kim serves as Director at Aktis Oncology, Inc. (AKTS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$15.03M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$15.03M

Companies Traded

AKTS

Active Period

Jan 2026

1 total trades

Most Recent

Buy AKTS

Jan 12, 2026 · $15.03M

Helen Susan Kim's Insider Trading at Aktis Oncology, Inc. (AKTS)

Buys

1 · $15.03M

Sells

0 · $0.00

Total Shares Bought

835,000

Total Shares Sold

AKTS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 12, 2026	Buy	835,000	$18.00	$15.03M	0

Related Insiders

Todd Foley

Director

AKTSBuy · Jan 12, 2026

GADICKE ANSBERT

10% Owner

AKTSBuy · Jan 12, 2026

Explore More Insider Trading Data

AKTS Insider Trading Activity

View all insider trades at Aktis Oncology, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity